Scenic Biotech
ID: 17658131Scenic Biotech is a developer of genomics and immunotherapy technology founded in 2017 by Thijn Brummelkamp.
6
Funding Rounds
$87.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Th*** Br********* |
|
- | |
| Se******* Ni**** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Scenic Biotech has raised a total of $76m in funding over 6 rounds.
Key Insights:
- Scenic Biotech Series A round, March 2022: $31m
- Scenic Biotech March 2022 Series A Funding Round: $31m
- Scenic Biotech June 2017 Series A Funding Round: $7m
- Scenic Biotech June 2017 Series A Funding Round: $7m
- Scenic Biotech B.V. Grant (money), June 2020: $3.71m
- Scenic Biotech B.V. Series A round, June 2017: $7.78m
Industries
Scenic Biotech is active in the following industries: